Pharmafile Logo

Medscape Education: Pioneering Pathways at ESMO 2025

October 6, 2025 |  

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

- PMLiVE

The team will be hosting 5 dynamic satellite symposia at the congress on topics including advances in metastatic breast cancer, personalizing care for prostate cancer, HER2-targeted therapy for gynecologic cancers, and other important topics in oncology. These symposia are designed to engage clinician learners and help them translate the latest data into action through downloadable slides and lively conversation between world-renowned experts. More information on the symposia and links to register are available here.

We invite Congress attendees to stop by the Medscape booth (#1009) in the exhibit hall to connect with the Medscape Oncology team and explore our latest innovations in oncology education, including the launch of the PIONEER Learning Center – PrecIsion Oncology: Navigating EvidEnce for Real-world impact.

“We have very exciting new education in topics like precision oncology that are going to help learners advance their care and reach more patients. We’re looking forward to great meetings and conversations with our oncology colleagues while we’re in Berlin so we can share more about it,” said Zhizhi Fiske

The Medscape team will be attending the congress from 17-20 October.

For more information on Medscape Oncology education, please contact Zhizhi Fiske

 

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professionals.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Showing Deep Expertise at ONS

The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024.  Medscape Oncology has deep expertise in the oncology...

MEDSCAPE’S NEW AGE OF CERTAINTY FOR CME

The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes is the core objective for...

Getting Past the Old-Fashioned View of Patient Advocacy

Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is getting past the perception of...

Mile High Impact at AAN 2024

The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this year’s event as Medscape presents...

Everything Was Peachy at ACC 2024 in Atlanta, GA

The annual ACC meeting has officially wrapped up in Atlanta, bringing a successful conference to a close for another year.  During the conference, members of the Medscape team hosted a...

A Woman Should Not Be Treated As a Small Man

What should the future of women’s healthcare look like? Two renowned physicians say it involves a multidisciplinary, holistic approach, where a group of different specialists work together to provide a...

Sharing Four Times the Impact at ACC 2024

ACC is kicking off next week in Atlanta, GA, and Medscape is heading south to join our cardiology colleagues. The Medscape team will be hosting booth #3431 on the exhibit...

Transforming San Diego for AAD 2024

The 2024 meeting of the American Academy of Dermatology has wrapped up, and Medscape has returned from a series of successful days at their booth, symposia, and offsite event. To...

The Power Dynamics of Women and Cancer

Women, Power, and Cancer: a Lancet commission, studied the interaction of women and cancer through a social justice and equity lens. What does ‘power’ mean when it comes to cancer...

Evaluating the Forces Shaping Women’s Healthcare

Gaps in women’s healthcare go beyond access and cost. Do clinicians have the tools they need to understand women’s health?